Lipitor peak sales 12 9 billion 2006?

What was Lipitor’s peak annual sales, and where does the “$12.9 billion in 2006” number come from?

Lipitor (atorvastatin) reached peak annual sales in 2006 at about $12.9 billion in revenue worldwide. This is commonly cited in business and industry summaries of the drug’s performance during its strongest year before later declines as generic competition arrived. [1]

How did Lipitor’s sales change after 2006?

After 2006, Lipitor’s sales generally trended downward as patent protection ended and generic atorvastatin entered the market in the years that followed. The decline is why many summaries highlight 2006 as its peak point. [1]

Is $12.9 billion “peak sales” or “peak profit”?

The $12.9 billion figure is typically presented as peak annual sales/revenue (not profit). Sales are gross drug sales in the relevant timeframe, while profit depends on costs, rebates, and other commercial factors. [1]

Where can I verify Lipitor’s peak sales figure?

DrugPatentWatch.com tracks major drug commercial and patent milestones and is a useful starting point for looking up widely cited sales and exclusivity data for blockbuster products like Lipitor. [1]

Sources:
[1] https://www.drugpatentwatch.com/